총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Ventyx Biosciences, Inc. (VTYX), 포함 24 건 매수 및 24 건 매도. 내부자 매수 총액은 $7M 내부자 매도 총액은 $2.56M.
최근 활동이 있는 주요 내부자에는 Subramaniam Somu, Hulme Allison, Gujrathi Sheila. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — VTYX
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2025-06-05 |
Subramaniam Somu |
Director |
RSU 부여 |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-06-05 |
Hulme Allison |
Director |
RSU 부여 |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-06-05 |
Gujrathi Sheila |
Director |
RSU 부여 |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-06-05 |
White William Richard |
Director |
RSU 부여 |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-06-05 |
Cadoret-manier Onaiza |
Director |
RSU 부여 |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-05-15 |
Forman Mark S |
Chief Medical Officer |
RSU 부여 |
3,000 |
$1.03 |
$3.09K |
3,000 |
| 2025-05-15 |
Gonzales Roy |
Senior VP, Finance |
RSU 부여 |
1,750 |
$1.03 |
$1.8K |
3,546 |
| 2025-04-02 |
Nuss John |
Chief Scientific Officer |
정보 매도 |
1,887 |
$1.07 |
$2.02K |
467,226 |
| 2025-03-28 |
Subramaniam Somu |
Director |
기타 (매도) |
1,335,450 |
- |
- |
4,032,213 |
| 2025-03-28 |
Nuss John |
Chief Scientific Officer |
옵션 행사 (매도) |
4,531 |
- |
- |
9,063 |
| 2025-03-28 |
Mohan Raju |
CEO and President |
옵션 행사 (매도) |
11,844 |
- |
- |
23,688 |
| 2025-03-10 |
Subramaniam Somu |
Director |
기타 (매도) |
1,735,306 |
- |
- |
5,367,663 |
| 2025-01-02 |
Moore Matthew Richard |
Chief Operating Officer |
RSU 부여 |
145,000 |
$2.14 |
$310.3K |
145,000 |
| 2025-01-02 |
Nuss John |
Chief Scientific Officer |
RSU 부여 |
170,104 |
$2.14 |
$364.02K |
170,104 |
| 2025-01-02 |
Mohan Raju |
CEO and President |
RSU 부여 |
700,000 |
$2.14 |
$1.5M |
700,000 |
| 2025-01-02 |
Forman Mark S |
Chief Medical Officer |
RSU 부여 |
85,000 |
$2.14 |
$181.9K |
85,000 |
| 2025-01-02 |
Gonzales Roy |
Senior VP, Finance |
RSU 부여 |
17,500 |
$2.14 |
$37.45K |
17,500 |
| 2024-12-27 |
Nuss John |
Chief Scientific Officer |
정보 매도 |
21,119 |
$2.36 |
$49.84K |
464,582 |
| 2024-12-23 |
Gujrathi Sheila |
Director |
정보 매수 |
130,000 |
$2.31 |
$300.57K |
130,000 |
| 2024-12-19 |
Nuss John |
Chief Scientific Officer |
정보 매도 |
13,161 |
$2.26 |
$29.68K |
485,701 |
| 2024-12-17 |
Nuss John |
Chief Scientific Officer |
옵션 행사 (매도) |
34,930 |
- |
- |
34,930 |
| 2024-12-17 |
Mohan Raju |
CEO and President |
옵션 행사 (매도) |
116,668 |
- |
- |
116,668 |
| 2024-12-10 |
Nuss John |
Chief Scientific Officer |
옵션 행사 (매도) |
193,557 |
$0.20 |
$38.71K |
- |
| 2024-11-25 |
Mohan Raju |
CEO and President |
정보 매수 |
261,752 |
$2.01 |
$524.94K |
2,175,028 |
| 2024-11-22 |
Mohan Raju |
CEO and President |
정보 매수 |
238,248 |
$1.83 |
$434.95K |
1,913,276 |
| 2024-08-30 |
Gonzales Roy |
Senior VP, Finance |
처분 |
70,000 |
$33.84 |
$2.37M |
- |
| 2024-08-12 |
Forman Mark S |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2024-08-12 |
Forman Mark S |
Chief Medical Officer |
RSU 부여 |
350,000 |
$1.95 |
$682.5K |
350,000 |
| 2024-06-24 |
Subramaniam Somu |
10 Percent Owner |
기타 (매도) |
641,327 |
- |
- |
7,102,969 |
| 2024-06-24 |
Nsv Partners Iii Lp |
10 Percent Owner |
기타 (매도) |
641,327 |
- |
- |
7,102,969 |
| 2024-06-10 |
Mohan Raju |
CEO and President |
옵션 행사 (매도) |
96,778 |
$0.20 |
$19.36K |
- |
| 2024-06-06 |
Subramaniam Somu |
10 Percent Owner |
RSU 부여 |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-06-06 |
Hulme Allison |
Director |
RSU 부여 |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-06-06 |
Gujrathi Sheila |
Director |
RSU 부여 |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-06-06 |
White William Richard |
Director |
RSU 부여 |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-06-06 |
Cadoret-manier Onaiza |
Director |
RSU 부여 |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-05-16 |
Moore Matthew Richard |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2024-05-16 |
Moore Matthew Richard |
Chief Operating Officer |
RSU 부여 |
320,000 |
$4.98 |
$1.59M |
320,000 |
| 2024-04-12 |
Subramaniam Somu |
10 Percent Owner |
기타 (매도) |
695,339 |
- |
- |
7,744,296 |
| 2024-04-12 |
Nsv Partners Iii Lp |
10 Percent Owner |
기타 (매도) |
695,339 |
- |
- |
7,744,296 |
| 2024-04-02 |
Krueger Christopher W |
Chief Business Officer |
정보 매도 |
1,651 |
$5.40 |
$8.92K |
284,999 |
| 2024-04-02 |
Nuss John |
Chief Scientific Officer |
정보 매도 |
1,651 |
$5.40 |
$8.92K |
264,998 |
| 2024-04-02 |
Auster Martin |
Chief Financial Officer |
정보 매도 |
1,405 |
$5.40 |
$7.59K |
24,303 |
| 2024-04-02 |
Mohan Raju |
CEO and President |
정보 매도 |
4,312 |
$5.40 |
$23.3K |
1,578,250 |
| 2024-03-28 |
Krueger Christopher W |
Chief Business Officer |
옵션 행사 (매도) |
4,531 |
- |
- |
13,594 |
| 2024-03-28 |
Nuss John |
Chief Scientific Officer |
옵션 행사 (매도) |
4,531 |
- |
- |
13,594 |
| 2024-03-28 |
Auster Martin |
Chief Financial Officer |
옵션 행사 (매도) |
4,531 |
- |
- |
13,594 |
| 2024-03-28 |
Mohan Raju |
CEO and President |
옵션 행사 (매도) |
11,843 |
- |
- |
35,532 |
| 2024-01-21 |
Subramaniam Somu |
10 Percent Owner |
RSU 부여 |
20,000 |
$1.97 |
$39.4K |
20,000 |
| 2024-01-21 |
Hulme Allison |
Director |
RSU 부여 |
20,000 |
$1.97 |
$39.4K |
20,000 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
